Costs of a successful public-private partnership for TB control in an urban setting in Nepal.

Costs of a successful public-private partnership for TB control in an urban setting in Nepal. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Costs of a successful public-private partnership for TB control in an urban setting in Nepal. Abstract Text:

Deepak K Karki,Tolib N Mirzoev,Andrew T Green,James N Newell,Sushil C Baral,

BACKGROUND: In South Asia a large number of patients seek treatment for TB from private practitioners (PPs), and there is increasing international interest in involving PPs in TB control. To evaluate the feasibility, effectiveness and costs of public-private partnerships (PPPs) for TB control, a PPP was developed in Lalitpur municipality, Nepal, where it is estimated that 50% of patients with TB are managed in the private sector. From the clinical perspective the PPP was shown to be effective. The aim of this paper is to assess and report on the costs involved in the PPP scheme. METHODS: The approach to costing took a comprehensive view, with inclusion of costs not only incurred by health facilities but also social costs borne by patients and their escorts. Semi-structured questionnaires and guided interviews were used to collect start-up and recurrent costs for the scheme. RESULTS: Overall costs for treating a TB patient under the PPP scheme averaged US$89.60. Start-up costs per patient represented 12% of the total budget. Half of recurrent costs were incurred by patients and their escorts, with institutional costs representing most of the rest. Female patients tended to spend more and patients referred from the private sector had the highest reported costs. CONCLUSION: Treating TB patients in the PPP scheme had a low additional cost, while doubling the case notification rate and maintaining a high success rate. Costs incurred by patients and their escorts were the largest contributors to the overall total. This suggests a focus for follow-up studies and for cost-minimisation strategies.

Costs of a successful public-private partnership for TB control in an urban setting in Nepal. Publishing Authors By Initials

DK Karki,TN Mirzoev,AT Green,JN Newell,SC Baral,

For similar persons: voluntary workers research abstracts see: persons: voluntary workers research

PUBMED ID PMID:

MEDLINE DATE:

Costs of a successful public-private partnership for TB control in an urban setting in Nepal. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: BMC public health

VOLUME: 7

Page Numbers: 84

Journal Abbreviation:

ISSN: 1471-2458

DAY: 18

MONTH: 05

YEAR: 2007

Costs of a successful public-private partnership for TB control in an urban setting in Nepal. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100968562

Costs of a successful public-private partnership for TB control in an urban setting in Nepal. Keywords Mesh Terms:

KEYWORDS: Voluntary Workers

MESH TERMS: organization & administration

Chemical & Substance for Abstract: Costs of a successful public-private partnership for TB control in an urban setting in Nepal. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Costs of a successful public-private partnership for TB control in an urban setting in Nepal.

AFFILIATION: Nuffield Centre for International Health and Development, Leeds Institute of Health Sciences and Public Health Research, University of Leeds, Leeds, UK. dekarki@wlink.com.np <dekarki@wlink.com.np>

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: BMC Public Health

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Costs of a successful public-private partnership for TB control in an urban setting in Nepal Related Publications

• Brachial plexus block as a sole anaesthetic technique in upper extremity fracture/dislocation in children: Subclavian perivascular vs parascalene approach.
• Chest Radiographs and their Reliability in the Diagnosis of Tuberculosis.
• Costs of a successful public-private partnership for TB control in an urban setting in Nepal.
• Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
• ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA. A DISEASE ENTITY IN CHILDHOOD.
• Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis.
• Hemoglobin status in children in the age group 6 to 60 months.
• Interferon-alpha2b restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by modulating CXC receptor ligand interaction.
• Kala-azar (Visceral Leishmaniasis) from Khotang.
• Mining gene-disease relationships from biomedical literature: weighting protein-protein interactions and connectivity measures.
• Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
• Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation.
• Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance.
• Neem leaf preparation induces apoptosis of tumor cells by releasing cytotoxic cytokines from human peripheral blood mononuclear cells.
• Oxidative stress in patients with benign prostate hyperplasia.